EXHIBIT 99.1
CONTACTS:
Charles Best
Chief Financial Officer
Biosource International, Inc.
[email protected]
Aspasia Knox
Investor Relations
(805) 383-5268
[email protected]
FOR IMMEDIATE RELEASE
November 16, 2000
BIOSOURCE INTERNATIONAL ANNOUNCES
WITHDRAWAL OF STOCK REPURCHASE PROGRAM
Camarillo, Calif. - November 16, 2000 - BioSource International, Inc.
(Nasdaq: BIOI) today announced that on Monday, October 30, 2000, its Board of
Directors approved a resolution to terminate its existing stock repurchase
program.
Commencing in April 1997, the Board previously authorized the repurchase of
a total of 1,450,000 shares of its common stock. Between April and September
1998, the Company purchased a total of 1.3 million shares of common stock at an
average share price of $6.29. No shares have been repurchased since September
1998.
BioSource International, Inc. is a broad based life sciences and genomics
company focused on providing solutions in the areas of functional genomics,
proteomics, as well as advanced drug discovery through the development,
manufacturing, marketing and distribution of unique biologically active reagent
systems which facilitate, enable and accelerate pharmaceutical development as
well as biomedical research.
This news release may contain forward-looking statements that involve risks and
uncertainties, including risks described from time to time in reports filed by
Biosource International, Inc. with the Securities and Exchange Commission,
including its most recently filed Annual Report on Form 10-K/A.
Page 5
